Rachel Humphrey

Synergy between chemotherapeutic agents and CTLA-4 blockade in preclinical tumor models

Maria Jure-Kunkel, J. Hunt, F. Lee, 2013, Cancer Immunology, Immunotherapy.

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.

Axel Hoos, Alessandro Testori, Axel Hauschild, 2011, The New England journal of medicine.

Improved Endpoints for Cancer Immunotherapy Trials

Sylvia Janetzki, Axel Hoos, J. Wolchok, 2010, Journal of the National Cancer Institute.

Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria

Axel Hoos, Jedd D. Wolchok, J. Wolchok, 2009, Clinical Cancer Research.